What does CUSIP 58490H107 represent in this 13F holders report?

CUSIP 58490H107 is the security identifier for MDNAF - Medicenna Therapeutics Corp. - COM used to aggregate holder disclosures.

How many institutions held MDNAF - Medicenna Therapeutics Corp. - COM in Q1 2024?

No institutional holders were reported for MDNAF - Medicenna Therapeutics Corp. - COM in Q1 2024; review adjacent reporting periods for trend context.

Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -128,978
Total reported value: $0
Price per share: $0.65
Number of holders: 0
Value change: -$40,918
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2024
Previous quarter: Q4 2023

Recent filing periods for CUSIP 58490H107:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

Medicenna Therapeutics Corp. - COM (MDNAF)

Q1 2024 13F Holders as of 31 Mar 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of MDNAF - Medicenna Therapeutics Corp. - COM as of Q1 2024.